Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-17-063683

Director sold 6,667 shares at $55.89 ($372,619)

  • Director acquired 6,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Wigzell Hans Lennart Rudolf · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2017-11-30 Exercise or conversion : show line 1 in the form +6,667 $7.38 $49,202 13,333 D
2017-11-30 Sale : show line 2 in the form −6,667 $55.89 $372,619 6,666 D
Open-market sales · 6,667 sh · avg $55.89 · $372,619

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2017-11-30 Exercise or conversion : show line 3 in the form Non-Qualified Stock Options (right to buy) −6,667 $7.38 $49,202 $7.38 2018-07-23 6,667 0 D
Loading xslF345X03/doc4.xml…